Coincidence of Mature Cystic Teratoma and Serotonin-producing Neuroendocrine Tumor of the Ileum

Abstract

Mature cystic teratomas are often found in gonadal sites, but are very rarely located extragonadally, for example, in retroperitoneum, mediastinum, central nervous system, lung, or liver. In the literature, only 10 cases of cystic teratoma originating from the diaphragm have been reported. Here, we report for the first time a metachronous occurrence of a benign mature cystic teratoma in the left diaphragm together with a serotonin-producing neuroendocrine tumor of the ileum. The 51-year-old, female patient received a partial resection of the ileum due to a neuroendocrine tumor (pT₃N₁M₀) 4 years ago. Furthermore, she was operated for a benign cystadenoma of the right ovary 3 years ago. In her past medical history, she had an appendectomy in her childhood and a subtotal thyroidectomy 10 years ago. To our knowledge, this is the first report describing the metachronous occurrence of benign mature cystic teratoma in the diaphragm and a highly differentiated neuroendocrine tumor of the ileum. The possible coincidence of both diseases is discussed.

Key words

benign cystic teratoma - neuroendocrine tumor - diaphragm

^*

^*  These authors contributed equally to this paper and share the first authorship.

• References

• 1 Kommoss F, Emond J, Hast J. Ruptured mature cystic teratoma of the ovary with recurrence in the liver and colon 17 years later: A case report. J Reprod Med 1990; 35: 827-831
• 2 Chen LM, Nelson SD, Berek JS. Recurrent mature cystic teratoma presenting as a perihepatic mass. Obstet Gynecol 1999; 94: 856
• 3 Okino H, Koga Y, Tsuneyoshi M, Takeda S. Metachronous mature cystic teratomas in the left ovary and bilateral diaphragm: report of a case. Surg Today 2006; 36: 1012-1014
• 4 Brohee G. Tumeurs primitives du diaphragme. Acta Chir Belg 1947; 7: 507-535
• 5 Desjacques R, Vuillard P, Douillet P. Kyste sereux peritoneal de la face inferieure du diaphragma (stimulant une tumeur gastrique benigne). Presse Med 1965; 73: 1297-1298
• 6 Dobek J, Majewski C, Moll J. A case of teratomatous cyst of the diaphragm. Przegl Lek 1967; 23: 797-799
• 7 Anan’ev VM, Gurevich SS, Rostovtseva ID. Differentiated teratoma of the diaphragm. Grudn Khir 1976; 1: 117-118
• 8 Dubost C, Hugues FC, Gossot D. Cystic teratoma of the diaphragm. A case report and literature review. J Chir 1984; 121: 273-276
• 9 Müller NL. CT features of cystic teratoma of the diaphragm. J Comput Assist Tomogr 1986; 10: 325-326
• 10 Rezgui-Marhoul L, Said W, Karkni A. A patient with a diaphragmatic mass. Rev Pneumol Clin 2003; 59: 381-383
• 11 Langley FA, Fox H. Ovarian tumors: classification, histogenesis and aetiology. In: Fox H, Wells M. (eds.) Obstetrical and gynaecological pathology. 4^th ed. New York: Churchill Livingstone; 1995: 727-742
• 12 Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008; 9: 61-72
• 13 Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?. J Am Coll Surg 1998; 187: 88-92
• 14 Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197: 29-37
• 15 Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y, Blumgart LH. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg 2000; 190: 432-445
• 16 Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol 2003; 10: 1171-1175
• 17 Moertel CG, Sauer WG, Dockerty MB, Baggenstoss AH. Life history of the carcinoid tumor of the small intestine. Cancer 1961; 14: 901-912
• 18 Thompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery 1988; 104: 1011-1017
• 19 Moertel CG. Karnofsky memorial lecture. An odyssey to in the land of small tumors. J Clin Oncol 1987; 5: 1502-1522
• 20 Anlauf M, Garbrecht N, Bauersfeld J, Schmitt A, Henopp T, Komminoth P, Heitz PU, Perren A, Klöppel G. Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch 2007; 451 (Suppl. 01) S29-S38
• 21 Landry CS, Scoggins CR, McMasters KM, Martin 2nd RC. Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol 2008; 97: 253-258
• 22 Costa F, Domenichini E, Garavito G, Medrano R, Mendez G, O’Connor J, Rojas W, Torres S, Younes RN, Delle Fave G, Oberg K. Management of neuroendocrine tumors: a meeting of experts from Latin America. Neuroendocrinology 2008; 88: 235-242
• 23 Müssig K, Oksüz MO, Dudziak K, Ueberberg B, Wehrmann M, Horger M, Schulz S, Häring HU, Pfannenberg C, Bares R, Gallwitz B, Petersenn S. Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET/CT in neuroendocrine tumors. Horm Metab Res 2010; 42: 599-606
• 24 Levanat S, Kappler R, Hemmerlein B. Analysis of the PTCH1 signaling pathway in ovarian dermoids. Int J Mol Med 2004; 14: 793-799
• 25 Shan J, Zhao W, Gu W. Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell 2009; 36: 469-476
• 26 Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004; 145: 5439-5447
• 27 Kobayashi Y, Arimoto H, Watanabe S. Occurrence of multiple primary cancer at the National Cancer Center Hospital 1962–1989. Jpn J Clin Oncol 1991; 21: 233-251
• 28 Flannery JT, Boice Jr JD, Devesa SS, Kleinerman RA, Curtis RE, Fraumeni Jr JF. Cancer registration in Connecticut and the study of multiple primary cancers 1935–82. Natl Cancer Inst Monogr 1985; 68: 13-24
• 29 Fendrich V, Waldmann J, Bartsch D, Schlosser K, Rothmund M, Gerdes B. Multiple Primary Malignancies in Patients With Sporadic Pancreatic Endocrine Tumors. J Surg Oncol 2008; 97: 592-595
• 30 Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 15; 79: 813-829
• 31 Brune M, Gerdes B, Koller M, Rothmund M. Neuroendocrine tumors of the gastrointestinal tract and second primary malignancies – which is dominant?. Dtsch Med Wochenschr 2003; 128: 2413-2417
• 32 Prommegger R, Ensinger C, Steiner P, Sauper T, Profanter C, Margreiter R. Neuroendocrine Tumors and Second Primary Malignancy – A Relationship with Clinical Impact?. Anticancer Research 2004; 24: 1049-1052